Most executives would never tolerate a major corporate expense with limited visibility, unclear pricing, conflicted advisors, and no meaningful performance benchmarks. Yet that is precisely how many companies manage employee healthcare costs.
The annual ritual is familiar. Rates increase, options narrow, deductibles rise, and leadership is told there is little anyone can do. HR presents the least painful selection from a disappointing spreadsheet, the executive team approves it, and everyone agrees to revisit the problem next year.
That is not strategy. It is managed surrender.
Employee healthcare costs are not simply an unavoidable market force. They are also the result of how employers buy, structure, measure, and govern healthcare benefits. If leaders continue treating healthcare as an expense they can only absorb or redistribute, they will continue paying for a system they do not control.
That was the central issue in my conversation with Donovan Pyle, CEO of Health Compass Consulting and author of Fixing Healthcare. Pyle, who previously worked on both the insurance carrier and brokerage sides of the industry, argues that employers already possess far more purchasing power than most realize. What they often lack is independent advice, useful visibility, and an operating model for exercising that power.
His position raises a question every executive should be willing to answer: Why is one of your largest expenses managed with less rigor than almost every other part of your business?
Employee Healthcare Costs Belong on the Executive Agenda
Healthcare benefits are often treated as an HR responsibility because they affect employees. That sounds logical until we consider the financial scale, operational risk, and strategic consequences involved.
According to figures Pyle cited in our conversation, U.S. employers spent approximately $1.3 trillion in one year to provide healthcare benefits covering about 164 million Americans. He estimates that roughly 25 percent of that spending, or $325 billion, was wasted. That equates to approximately $4,000 per employee. These are Pyle’s figures and were not independently validated for this article, but the scale of the claim should get an executive’s attention.
A cost of that magnitude is not merely a benefits issue. It affects margins, compensation, hiring capacity, investment decisions, employee retention, and the organization’s ability to compete. Every unnecessary healthcare dollar has an opportunity cost somewhere else in the business.
Yet many leaders have effectively removed themselves from the decision. They have accepted the industry narrative that healthcare costs rise every year and that the only meaningful response is to change insurers, narrow coverage, increase employee contributions, or raise deductibles.
That narrative is convenient for the organizations benefiting from the status quo. It is much less convenient for employers and employees paying the bill.
The Problem Is Not Just Price. It Is Misaligned Advice
Pyle’s first recommendation is also the most provocative: Employers must determine whether their benefits advice is genuinely aligned with their financial interests.
Most executives assume their benefits broker is responsible for helping the company maximize the value of its healthcare investment. Pyle challenges that assumption. He contends that the traditional brokerage model developed primarily as a distribution channel for insurance carriers and pharmacy benefit managers. In many arrangements, compensation increases as premiums or costs rise.
Not every broker relationship is identical, and compensation structures should be examined rather than assumed. Still, the executive question is straightforward: Who pays your advisor, how are they paid, and what financial incentives shape the recommendations reaching your desk?
If leadership cannot answer those questions clearly, the organization does not have an advisory relationship. It has a visibility problem.
Pyle offered a sharp analogy. Imagine hiring a CPA to protect your company’s interests, only to discover that the CPA is paid by the IRS. Most executives would immediately recognize the conflict. In healthcare, similarly misaligned arrangements have become familiar enough that companies rarely challenge them.
Familiarity does not eliminate a conflict. It simply makes the conflict easier to ignore.
Healthcare Benefits Should Be Managed as a Supply Chain
The more useful shift is to stop viewing healthcare benefits as a fixed insurance product and start treating them as a supply chain.
Employers and employees ultimately fund the hospitalizations, surgeries, laboratory work, imaging, prescriptions, and other services moving through that supply chain. The insurer may administer claims, provide network access, and perform other contracted functions, but the economic burden still reaches the employer and its workforce.
Once leaders understand that dynamic, the management questions change. Instead of asking which renewal option is cheapest, they can ask where value is being lost, which vendors profit from rising costs, how prices compare, whether employees can access high-quality care, and how the benefits structure supports the company’s workforce strategy.
This is standard operating discipline everywhere else. Companies set key performance indicators, establish goals, compare performance, design multiyear roadmaps, and hold partners accountable. Healthcare frequently escapes that discipline because executives have been conditioned to believe the system is too complex to manage.
Complexity is not an excuse for abandoning governance. It is the reason governance is required.
Pyle recommends that employers quantify their current position across several dimensions of benefits value, compare performance where reliable benchmarks are available, set specific goals, develop a roadmap, and execute against it. The exact measures will vary by organization, but the principle is universal: You cannot manage an expense you have agreed not to understand.
Price Opacity Is Expensive
One of the clearest signs of dysfunction is the enormous variation in healthcare prices.
Pyle described purchasing an MRI in Orlando for approximately $400 while people in the same area may pay more than $4,000 for comparable imaging. He also stated that healthcare prices in Orlando can vary by as much as 1,100 percent. Those figures reflect his experience and analysis, but the underlying executive issue is broader than one city or procedure.
In a functioning market, buyers can compare the price and value of what they are purchasing. In healthcare, employers often fund services without having practical visibility into either. Employees may make decisions without knowing the price, the quality difference, or the financial effect on themselves and their employer.
No executive would knowingly authorize an employee to buy a routine business input for ten times the available price without a compelling difference in quality or service. When healthcare is involved, however, companies tolerate extreme variation because they assume someone else is managing it.
Often, no one is.
Price transparency alone will not fix healthcare. Employees cannot be expected to become professional healthcare procurement specialists while trying to obtain treatment. Employers need systems, incentives, guidance, and vendor arrangements that make better choices easier rather than merely making more data technically available.
That is workplace design, not just plan design.
Better Benefits Do Not Have to Mean Higher Costs
One of the most damaging assumptions in employee benefits is that cost reduction must come at the employee’s expense. It usually arrives as a higher deductible, a narrower network, a larger payroll deduction, or reduced coverage. The company spends less by transferring more financial risk to its people.
That may improve one line in the budget, but it can create problems elsewhere. Employees delay care, experience greater financial stress, struggle to navigate narrower options, and perceive the benefits program as another cost being imposed on them. The employer may then absorb the consequences through dissatisfaction, distraction, absenteeism, and retention pressure.
Pyle described working with a South Florida technology company that had historically been presented with a limited set of conventional insurance options. His firm helped build a more customized arrangement that included a differently structured pharmacy benefit relationship and broader access to providers.
According to Pyle, the company saved more than $3,000 per employee in the first year while improving network access and benefits. Some high-cost claimants gained access to higher-quality providers, and the company waived their out-of-pocket responsibility when they selected those options. These are company-reported results from Pyle’s client work and have not been independently validated here.
The important lesson is not that every employer will produce the same result. It is that the usual trade-off between lower employer cost and worse employee experience may be a design failure rather than an economic law.
When employees are rewarded for choosing better-value care, cost management and employee experience can support each other. That is a more intelligent strategy than handing employees a larger deductible and calling it consumerism.
Connect Benefits Strategy to Business Strategy
A benefits program should not exist as an isolated annual purchasing exercise. It should support the company’s human capital strategy, which in turn should support its business objectives.
For a company competing for scarce talent, access and employee experience may carry greater strategic weight. For a business operating on narrow margins, reducing avoidable spending may be critical. A geographically distributed workforce may require different network decisions than a workforce concentrated in one market.
The right benefits structure depends on the organization’s workforce, financial model, risk tolerance, operating geography, and strategic priorities. That is why choosing the cheapest option from a renewal spreadsheet is not enough. The spreadsheet may compare products without questioning whether the company should be buying, funding, or configuring those products in the same way.
Executives should expect the benefits function to answer business questions, not merely insurance questions. What outcomes are we trying to produce? Where are we currently losing value? Which costs are preventable? What does the employee experience look like when someone actually needs care? Which vendors are accountable for improving those outcomes?
If a benefits strategy cannot connect to a business objective, it is probably not a strategy yet.
What Executives Should Do Differently
The first move is not firing a broker, changing an insurer, or purchasing another solution. It is establishing clarity.
Leadership should request full disclosure of every form of direct and indirect compensation connected to the benefits program. Executives should understand who pays each advisor and vendor, how compensation is calculated, what incentives exist, and whether any party accepts fiduciary responsibility to the employer.
The company should then establish a measurable baseline. That includes understanding current spending, plan performance, employee access, network constraints, prescription arrangements, major cost concentrations, and the quality of available data. Benchmarking can be useful, but only when the comparisons are relevant and the methodology is credible.
From there, leadership can define what success means over multiple years. Cost matters, but it should not stand alone. A disciplined strategy may also consider employee financial exposure, access to appropriate providers, navigation experience, decision speed, administrative burden, and alignment with talent goals.
The goal is not to make the CEO an expert in medical pricing or pharmacy contracts. The goal is to ensure someone accountable to the company is managing those areas with transparent incentives, credible information, and executive oversight.
Delegation is good management. Blind delegation is not.
Reform Requires More Than a New Vendor
There are limits and risks to this approach. Alternative funding structures, specialized vendors, and customized networks are not automatically better simply because they are different. A confusing collection of point solutions can create administrative complexity, fragmented accountability, and a miserable employee experience.
Data quality also matters. Leaders should be skeptical of savings projections based on weak assumptions, selective comparisons, or vendor-controlled calculations. Promised savings are not realized savings, and lower unit prices do not guarantee better overall outcomes.
Employee communication is another condition for success. A technically efficient plan can fail if employees do not understand how to use it or believe that every change is designed to deny care. The strategy must make high-value choices accessible, understandable, and personally beneficial.
Finally, executive sponsorship cannot disappear after the contract is signed. Healthcare cost management requires the same cadence as other strategic initiatives: performance reviews, clear ownership, measurable targets, corrective action, and periodic reassessment.
Replacing one unquestioned vendor with another does not constitute transformation. It merely changes who receives the check.
Stop Buying Healthcare Blind
Employee healthcare costs will not become manageable because leaders complain about renewal rates, wait for regulatory rescue, or push another increase onto employees. They become manageable when executives treat benefits as a strategic investment and healthcare as a supply chain requiring visibility, alignment, and accountability.
Pyle’s most important point is not that every company should follow one funding model or purchase one specific solution. It is that employers already have choices they may not be exercising because the traditional system has trained them to expect less.
The immediate executive challenge is simple: Before approving your next benefits decision, require a clear accounting of who profits, where value is lost, what alternatives were evaluated, and how success will be measured.
If your company cannot answer those questions, do not approve another renewal on autopilot. Stop buying blind.
Listen to the podcast episode on C-Suite Radio: Disrupt & Innovate | C-Suite Network
Watch the episode: Reclaiming Control of Employee Benefits
Check our websites: LcubedConsulting.com and AI ValuePath™
This article was drafted with the assistance of an AI writing assistant, Abacus.AI’s ChatLLM Teams, the image was generated with Abacus AI Studio and edited by Lisa L. Levy for accuracy, tone, and final content.
